Showing 1 - 6 results of 6 for search 'Derralynn Hughes', query time: 0.01s Refine Results
  1. 1
    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation

    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation by Derralynn Hughes, Andrew Lenny, Koonal Shah, Louise Longworth, Giovanna Devercelli, Olulade Ayodele

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis

    Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis by Simona D’Amore, Kenneth Eric Poole, Uma Ramaswami, Derralynn Hughes, Kathleen Page, Antonio Giovanni Solimando, Angelo Vacca, Timothy Martin Cox, Patrick Deegan

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom

    Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom by Lena Hubig, Anna-Katrine Sussex, Alasdair MacCulloch, Derralynn Hughes, Ryan Graham, Liz Morris, Syed Raza, Andrew J. Lloyd, Amanda Sowinski, Katy Gallop

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    An analytical framework for enhancing cancer care efficiency in North London hospitals

    An analytical framework for enhancing cancer care efficiency in North London hospitals by Elizabeth A. Cooke, Nadia A.S. Smith, Donna Chung, Ben Goretzki, Spencer A. Thomas, Adrienne Flanagan, Craig Gerrand, Neal Navani, Prabhakar Rajan, Ashoke Roy, Clare Schilling, Ellie Smyth, Paul Stimpson, Sandra J. Strauss, Derralynn Hughes

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    P236: Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study

    P236: Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study by John Bernat, Myrl Holida, Stephen Waldek, William Wilcox, Nicola Longo, Ozlem Goker-Alpan, Eric Wallace, Patrick Deegan, Camilla Tondel, François Eyskens, Ulla Feldt-Rasmussen, Derralynn Hughes, Antonio Pisani, Ankit Mehta, Khan Nedd, David Warnock, Giovanni Piotti, Meng Wang, Einat Almon-Brill, Sari Alon, Raul Chertkoff, Ales Linhart

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

    Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths... by Richard D Neal, Amitava Banerjee, Deenan Pillay, Vahe Nafilyan, Clare Turnbull, Harry Hemingway, Bryan Williams, Mark Lawler, Monica Jones, Kathy Pritchard-Jones, Mahdad Noursadeghi, Richard Sullivan, Graham R Foster, Ben Humberstone, Alvina G Lai, Laura Pasea, Geoff Hall, Wai Hoong Chang, Michail Katsoulis, David Linch, Derralynn Hughes, Martin D Forster, Natalie K Fitzpatrick, Kathryn Boyd, Tariq Enver, Matt Cooper, Charlie Davie

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: